Featured Presentations
Canaccord Genuity 38th Annual Growth Conference
- Date: August 8, 2018
- Webcast: Replay
VBI Vaccines Corporate Overview
- Updated: June 6, 2018
- Download Presentation: PDF
Preventative CMV Vaccine Phase 1 Study Results
- Date: May 10, 2018
- Webcast: Replay
Sci-B-Vac® Phase 3 Program Clinical and Regulatory Update
- Date: July 12, 2017
- Webcast: Replay
Recent Events
BMO Capital Markets 2017 Healthcare Conference
- Date: Thursday, December 14, 2017
- Webcast: Replay
Ladenburg Thalmann 2017 Healthcare Conference
- Date: September 26, 2017
- Webcast: Replay
Cantor Fitzgerald Global Healthcare Conference
- Date: September 26, 2017
- Webcast: Replay
Immuno-Oncology Summit 2017
- Date: August 30, 2017
- Download Presentation: Harnessing the Immunogenicity of Foreign Viral CMV Antigens to Target Solid Tumors
Jefferies 2017 Global Healthcare Conference
- Date: June 9, 2017
- Webcast: Replay
World Vaccine Congress
- Date: April 11, 2017
- Download Presentation: VBI-1901: Harnessing Foreign Viral CMV Antigens to Re-Stimulate Anti-Tumor Immunity
World Vaccine Congress
- Date: April 11, 2017
- Download Presentation: Sci-B-Vac®: Hepatitis B Vaccine Phase III Program Update
10th Vaccine Congress
- Date: September 5, 2016
- Download Presentation: eVLP Delivery of an Optimized Form of CMV gB Antigen for Prophylactic Vaccination against Congenital CMV
4th Annual Immuno-Oncology Summit
- Date: August 31, 2016
- Download Presentation: eVLP Delivery of Novel Foreign Antigens Elicits Polyvalent Anti-Tumor Immunity
Hepatitis B Key Opinion Leader Meeting
- Date: June 13, 2016
- Download Presentation: Advances in Vaccination Against Hepatitis B
- Webcast: Replay
Jefferies Healthcare Conference
- Date: June 10, 2016
- Webcast: Replay
World Vaccine Congress Washington
- Date: March 30, 2016
- Download Presentation: More Foreign than Neo: Harnessing the Power of Viral CMV Antigens in Cancer Vaccines
Keystone Symposia Cancer Vaccines Conference
- Date: March 7, 2016
- Download Poster: CMV gB/pp65 eVLPs Formulated with GM-CSF as a Therapeutic Vaccine against GBM
28th Annual ROTH Conference
- Date: March 15, 2016
18th Annual BIO CEO & Investor Conference
- Date: February 9, 2016
